Title
Noninvasive rapid cardiac magnetic resonance for the assessment of cardiomyopathies in low-middle income countries
Date Issued
01 January 2021
Access level
open access
Resource Type
review
Author(s)
Seraphim A.
Katekaru D.
Abdel-Gadir A.
Han Y.
Westwood M.
Walker J.M.
Moon J.C.
Herrey A.S.
University College London
Publisher(s)
Taylor and Francis Ltd.
Abstract
Introduction: Cardiac Magnetic Resonance (CMR) is a crucial diagnostic imaging test that redefines diagnosis and enables targeted therapies, but the access to CMR is limited in low-middle Income Countries (LMICs) even though cardiovascular disease is an emergent primary cause of mortality in LMICs. New abbreviated CMR protocols can be less expensive, faster, whilst maintaining accuracy, potentially leading to a higher utilization in LMICs. Areas covered: This article will review cardiovascular disease in LMICs and the current role of CMR in cardiac diagnosis and enable targeted therapy, discussing the main obstacles to prevent the adoption of CMR in LMICs. We will then review the potential utility of abbreviated, cost-effective CMR protocols to improve cardiac diagnosis and care, the clinical indications of the exam, current evidence and future directions. Expert opinion: Rapid CMR protocols, provided that they are utilized in potentially high yield cases, could reduce cost and increase effectiveness. The adoption of these protocols, their integration into care pathways, and prioritizing key treatable diagnoses can potentially improve patient care. Several LMIC countries are now pioneering these approaches and the application of rapid CMR protocols appears to have a bright future if delivered effectively.
Start page
387
End page
398
Volume
19
Issue
5
Language
English
OCDE Knowledge area
Sistema cardiaco, Sistema cardiovascular
Subjects
Scopus EID
2-s2.0-85106264089
PubMed ID
Source
Expert Review of Cardiovascular Therapy
ISSN of the container
14779072
Sponsor(s)
KM is funded by The Peruvian Scientific, Technological Development and Technological Innovation (FONDECYT) and Global Engagement Office, University College London. JMW receives support from the National Institute for Health Research University College London Hospitals Biomedical Research Centre and UCLH Charity–Greenbaum/McClean Legacy.
Sources of information:
Directorio de Producción CientÃfica
Scopus